Hypoxia-activated prodrug combining site-specific chemotherapy and light-driven photothermal therapySENSORS AND ACTUATORS B-CHEMICALIF7.72024-09-010PRE
A promising strategy for synergistic cancer therapy by integrating a photosensitizer into a hypoxia-activated prodrugEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92022-12-0116PRE
A Hypoxia-Activated Prodrug Conjugated with a BODIPY-Based Photothermal Agent for Imaging-Guided Chemo-Photothermal Combination TherapyACS APPLIED MATERIALS & INTERFACESIF8.22022-09-0524PRE
未登录
荣誉奖项
.png){kind=icon}
